Margaret Ann van Kempen's most recent trade in Core Laboratories N.V. was a trade of 14,507 Common Shares done . Disclosure was reported to the exchange on April 1, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Core Laboratories NV | Margaret Ann van Kempen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 14,507 | 20,004 (0%) | 0% | 0 | Common Shares | |
| Core Laboratories NV | Margaret Ann van Kempen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 14,507 | 0 | - | - | Restricted Shares | |
| Core Laboratories NV | Margaret Ann van Kempen | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.10 per share. | 01 Apr 2021 | 7,181 | 12,823 (0%) | 0% | 30.1 | 216,148 | Common Shares |